Is Monte Rosa Therapeutics, Inc. overvalued?

Monte Rosa Therapeutics, Inc. (GLUE) — key valuation metrics and fundamentals.

No verdict

Price

$9.37

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$800.7M

Dividend yield

0.0%

Return on equity

-30.1%

Sector

Healthcare

Fair value compares GLUE's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.

Related stocks